SCHEMBL12436364

SCHEMBL12436364

Cc1ccc(Cl)c(CC(=O)O)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.42
PKM P14618 1/20 0.42
HTT P42858 1/20 0.42
AKR1B1 P15121 1/20 0.41
HSD17B10 Q99714 2/20 0.41
MEN1 O00255 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 1/20 0.41
GABRR1 P24046 1/20 0.41
ALDH1A1 P00352 3/20 0.40
PTGDR2 Q9Y5Y4 2/20 0.40
P2RX7 Q99572 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MAPK1 P28482 1/20 0.38
AGBL2 Q5U5Z8 1/20 0.38
MAPT P10636 1/20 0.37
EGFR P00533 1/20 0.37
HPGD P15428 2/20 0.37
CA2 P00918 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29686979 0.85 AKR1B1 (0.44) KDM4EAKR1B1MEN1KMT2AGABRR1
SCHEMBL19975190 0.85 AKR1B1 (0.44) KDM4EAKR1B1MEN1KMT2AGABRR1
SCHEMBL27997592 0.81 KDM4E (0.44) KDM4EAKR1B1HSD17B10CYP2C19KMT2A
SCHEMBL27543528 0.78 AKR1B1 (0.41) KDM4EAKR1B1GABRR1ALDH1A1PTGDR2
SCHEMBL27654199 0.77 TDP1 (0.44) KDM4EHTTAKR1B1HSD17B10ALDH1A1
SCHEMBL17300098 0.76 KDM4E (0.61) KDM4EPKMHTTHSD17B10MEN1
SCHEMBL21736916 0.76 S1PR4 (0.49) KDM4EHTTHSD17B10MEN1CYP2C9
SCHEMBL8234812 0.75 AKR1B1 (0.39) KDM4EAKR1B1CYP2C9ALDH1A1PTGDR2
SCHEMBL4917922 0.75 MEN1 (0.55) KDM4EPKMHTTHSD17B10MEN1
SCHEMBL3018109 0.74 KDM4E (0.41) KDM4EAKR1B1CYP2C19GABRR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011095997-A1 BENZAMIDE COMPOUNDS AS GLUCOKINASE ACTIVATORS AND THEIR PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2011-08-11 WO disclosed